Phase 2 Tumor, Solid Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
TumorGlow Intraoperative Molecular Imaging (IMI)
Tumor, Solid
University of Pennsylvania500 enrolled1 locationNCT04723810
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 1Phase 2
LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.
Tumor, Solid
Leucid Bio17 enrolled2 locationsNCT06193902
Recruiting
Phase 2
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Tumor, Solid
Centre Francois Baclesse52 enrolled3 locationsNCT05943119
Recruiting
Phase 1Phase 2
A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment
Tumor, Solid
Evopoint Biosciences Inc.132 enrolled1 locationNCT06987500
Recruiting
Phase 1Phase 2
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
Solid TumorSolid Tumor, AdultSolid Tumor Cancer+4 more
Avelos Therapeutics Inc.36 enrolled3 locationsNCT06911333
Recruiting
Phase 1Phase 2
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Advanced Solid TumorCancerNon-small Cell Lung Cancer+4 more
OncoResponse, Inc.168 enrolled4 locationsNCT06090266